Panthera claws £10m investment round
Preston-based Panthera Biosciences, which recruits patients and runs clinical trials on behalf of pharmaceutical and contract research organisations, has secured £10m from BGF and Gresham House Ventures.
Panthera conducts trials in specialist areas such as oncology, NASH, neurology and vaccines as well as those treated in general practice.
Tangany pocketing £5.8m for crypto storage platform
Tangany, a platform for the custody of crypto assets, is set to raise €7m (£5.8m) in a seed round led by Nauta Capital. Tangany’s Wallet as a Service (WaaS) provides highly secure storage for digital assets such as Bitcoin, Ethereum and NFTs.
The platform offers highly secure custody of digital assets on the blockchain of which it has €400m (£333m) under custody.
AMLo detects £2.5m more investment
Newcastle University spinout AMLo Biosciences, a medical device company specialising in the early detection of skin cancers, has secured further investment totalling £2.45m.
AMLo’s prognostic test for early-stage skin cancer can accurately identify genuinely low risk, early-stage melanomas. The round included new investment from Ascension’s Life Fund and Conduit’s EIS Impact Fund, re-investment from NorthStar Ventures, Future Planet Capital’s BIF Opportunities Fund, Esperante, and several angel investors.
HomeLink Healthcare nurses £2.2m investment
HomeLink supports the NHS by providing nursing and rehabilitation services to patients in their own homes. These services deliver a range of clinical interventions, including wound care, intravenous therapies, physiotherapy, rehabilitation and a “virtual ward” solution.
School hire platform fundraises further £1m
The Manchester-based start-up works with schools across the country to hire out their facilities outside of school hours, to enable them to generate much-needed revenue which can be invested back into their facilities.
Social-conscious impact fund handed £1m
SIS Ventures, a VC which invests in Scotland’s high-impact early-stage businesses, has secured £1m from Chroma Ventures for its Impact First fund. This is in addition to a further £700,000 already committed by other investors.
The Impact First fund backs Scottish businesses whose social and environmental aims are aligned to the United Nations sustainable development goals. Investments to date include Dxcover, which provides earlier diagnosis for life-limiting diseases, and SOLASTA Bio, which aims to protect worldwide food security and ecosystems.